India, Aug. 22 -- Fujifilm Biotechnologies is preparing to open the first phase of its massive biologics manufacturing campus in Holly Springs, North Carolina, a site designed to rank among the largest of its kind in the world.
At the heart of the complex is a central hallway stretching the length of three football fields, connecting four separate buildings that will anchor the company's biologics production.
Two of the facilities are scheduled to begin operations this fall, producing the drug substance, the essential foundation of biologic therapies, for Fujifilm's inaugural customers, Regeneron and Johnson & Johnson. The remaining two buildings are still under construction and slated to open in 2028, expanding the site's production scal...